1. Anonymous (2015) Guidance for industry and review staff: nonclinical safety evaluation of reformulated drug products and products intended for administration by an alternate route. U.S. Department of Health and Human Services, Food and Drug Administration.
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm079245.pdf
2. Aran JM, Chappert C, Dulon D, Erre JP, Aurousseau C (1995) Uptake of amikacin by hair cells of the guinea pig cochlea and vestibule and ototoxicity: comparison with gentamicin. Hear Res 82(2):179–183
3. Campo P, Maguin K (2007) Solvent-induced hearing loss: mechanisms and prevention strategy. Int J Occup Med Environ Health 20(3):265–270.
https://doi.org/10.2478/v10001-007-0031-3
4. Chen GD, Chi LH, Kostyniak PJ, Henderson D (2007) Styrene induced alterations in biomarkers of exposure and effects in the cochlea: mechanisms of hearing loss. Toxicol Sci 98(1):167–177.
https://doi.org/10.1093/toxsci/kfm078
5. Crofton KM, Lassiter TL, Rebert CS (1994) Solvent-induced ototoxicity in rats: an atypical selective mid-frequency hearing deficit. Hear Res 80(1):25–30